Appendix A: CBCRP 2009 Research Review Committees
Expert committees review for scientific merit all research applications submitted to the CBCRP. To minimize conflicts of interest, review committees are composed of experts from outside California. These experts include scientists highly knowledgeable about the broad topic of the applications they consider. Each review committee also has advocate reviewers. These are women and men active in breast cancer advocacy organizations, many of them also living with the disease. The review committees for 2009 are listed below.
Special Research Initiatives: Chemicals Policy Review Committee
Chair:Suzanne Fenton, Ph.D. Scientific Reviewers:Daryl Ditz, Ph.D. |
Ronald Melnick, Ph.D. Ruthann A. Rudel, M.S. Advocate Reviewer:Anna Cluxton, MBA |
Special Research Initiatives: Demographic Questions Review Committee
Chair:Charmaine D.M. Royal, Ph.D. Scientific Reviewers:Hector G. Balcazar, Ph.D. |
Judy Bradford, Ph.D. Advocate Reviewer:Vernal H. Branch |
Special Research Initiatives: Survival Review Committee
Chair:Blase Polite, MD, MPP Scientific Reviewers:Dawn L. Hershman, M.D., M.S. |
Stephanie Smith-Warner, Ph.D. Advocate Reviewer:Jacquelin Holland |
Special Research Initiatives: Biological/Ecological Model Review Committee
Chair:Sarah Gehlert, Ph.D. Scientific Reviewers:Anthony C. Gatrell, Ph.D. |
Neil Theise, M.D. Advocate Reviewer:Vernal Branch |
Special Research Initiatives: Statistical Models Review Committee
Chair:Julia G. Brody, Ph.D. Scientific Reviewers:Mousumi Banerjee, Ph.D. Aedin Culhane, Ph.D. |
Richard D. Day, Ph.D. Edwin S. Iversen, Ph.D. Advocate Reviewer:Susan Pelletier |
Core Funding: Community Research Collaborations/Sociocultural/Health Policy Review Committee
Chair:Shiraz Mishra, M.B.B.S., Ph.D. Scientific Reviewers:Deborah Bowen, Ph.D. Patricia Carney, Ph.D. Lori Crane, Ph.D., M.P.H. Alecia Fair, Dr.PH Laura Linnan, Sc.D., CHES |
Armin Weinberg, Ph.D. Mayumi Willgerodt, Ph.D. Advocate Reviewers:Christine Carpenter Maryellen Delapine California Advocate Observer:Linda Cady Ad-Hoc Reviewer:Gary Morrow, Ph.D. |
Core Funding: Innovative Treatments/Earlier Detection Review Committee
Chair:Patricia LoRusso, D.O. Scientific Reviewers:Ralph Bernacki, Ph.D. Ulrich Bierbach, Ph.D. David Boothman, Ph.D. Sandra Demaria, M.D. Leisha Emens, M.D., Ph.D. Silvia Formenti, M.D. Andrew Karellas, Ph.D. Paul Kinahan, Ph.D. Keith Knutson, Ph.D.
|
Mark Pagel, Ph.D. Eva Sevick-Muraca, Ph.D. Nancy Templeton, Ph.D. Lily Yang, M.D., Ph.D. Advocate Reviewers:David Baker Beverly Canin Marjorie Gallece Roberta Gelb California Advocate Observer:Diane Heditsian Ad-Hoc Reviewers:Julie Lang, M.D. Abenaa Brewster, M.D., M.H.S. |
Core Funding: Pathogenesis Review Committee
Chair:Danny Welch, Ph.D. Scientific Reviewers:Hava Avraham, Ph.D. Geoffrey Clark, Ph.D. Qihong Huang, Ph.D. Cheryl Jorcyk, Ph.D. James McCarthy, Ph.D. Harikrishna Nakshatri, Ph.D. Susan Pories, M.D., FACS
|
Pranela Rameshwar, Ph.D. Jasti Rao, Ph.D. Patricia Schoenlein, Ph.D. Joyce Schroeder, Ph.D. Advocate Reviewers:Jessica Henderson, Ph.D. Beverly Parker, Ph.D. Diane Roth Sandra Stanford California Advocate Observer:Karen Huyser, Ph.D. |
Core Funding: Etiology, Prevention & Progression Review Committee
Chair:Peggy Porter, M.D. Scientific Reviewers:Rajesh Agarwal, Ph.D. Stephen Barnes, Ph.D. Abenaa Brewster, M.D., M.H.S. James DiRenzo, Ph.D. Stephen Grant, Ph.D. Julie Lang, M.D. Joan Lewis-Wambi, Ph.D. Thomas Ludwig, Ph.D. |
Mark Pegram, M.D. Indira Poola, Ph.D. Weston Porter, Ph.D. Carla Van Den Berg, Pharm.D. Advocate Reviewers:Kimberly Newman-McCown Nancy Singleton Maria Wetzel Kimberly Wright California Advocate Observer:Jeannette Morrow |

